APO RESEARCH · REPORT
Aprotinin
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Product & engineering
Understand the product.
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Selected research
Industry Growth & Trends
Global Aprotinin Industry Growth and Trends Forecast to 2032
Market perspective
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Global Aprotinin key players include Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, etc. Global top four manufacturers hold a share over 25%.
India is the largest market, with a share about 20%, followed by China, and North America, both have a share about 35 percent.
Read the full market overview
In terms of product, Aprotinin (From bovine lung) is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Pharmaceuticals, followed by Scientific Research and Experiment.
Report Scope
This report provides a structured, data-driven view of the global Aprotinin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Aprotinin market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aprotinin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aprotinin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Aprotinin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Aprotinin Market by Company
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Aprotinin Segment by Type
Aprotinin (From bovine lung)
Recombinant Aprotinin
Aprotinin Segment by Application
Pharmaceuticals
Scientific Research and Experiment
Aprotinin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprotinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aprotinin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprotinin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aprotinin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Aprotinin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aprotinin (From bovine lung)
- Recombinant Aprotinin
Applications
- Pharmaceuticals
- Scientific Research and Experiment
Companies covered
- Sigma-Aldrich
- BeiJing Geyuantianrun Bio-tech
- Cayman Chemical
- Taj Pharmaceuticals Limited
- Guangdong Techpool Bio-pharma
- Dadeli
- A.S.Joshi&Company
- Enzymeking Biotechnology
- AdooQ BioScience
- ProSpec
- Yaxin Biotechnology
- AMRESCO
- PanReac AppliChem
- Runhao
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Aprotinin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Aprotinin Sales Estimates and Forecasts (2021-2032)
- 1.3 Aprotinin Market by Type
- 1.3.1 Aprotinin (From bovine lung)
- 1.3.2 Recombinant Aprotinin
- 1.4 Global Aprotinin Market Size by Type
- 1.4.1 Global Aprotinin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Aprotinin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Aprotinin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Aprotinin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Aprotinin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Aprotinin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Aprotinin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Aprotinin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Aprotinin Industry Trends
- 2.2 Aprotinin Industry Drivers
- 2.3 Aprotinin Industry Opportunities and Challenges
- 2.4 Aprotinin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Aprotinin Revenue (2021-2026)
- 3.2 Global Top Players by Aprotinin Sales (2021-2026)
- 3.3 Global Top Players by Aprotinin Price (2021-2026)
- 3.4 Global Aprotinin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Aprotinin Major Company Production Sites & Headquarters
- 3.6 Global Aprotinin Company, Product Type & Application
- 3.7 Global Aprotinin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Aprotinin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Aprotinin Players Market Share by Revenue in 2025
- 3.8.3 2025 Aprotinin Tier 1, Tier 2, and Tier 3
4 Aprotinin Regional Status and Outlook
- 4.1 Global Aprotinin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Aprotinin Historic Market Size by Region
- 4.2.1 Global Aprotinin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Aprotinin Sales in Value by Region (2021-2026)
- 4.2.3 Global Aprotinin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Aprotinin Forecasted Market Size by Region
- 4.3.1 Global Aprotinin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Aprotinin Sales in Value by Region (2027-2032)
- 4.3.3 Global Aprotinin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aprotinin by Application
- 5.1 Aprotinin Market by Application
- 5.1.1 Pharmaceuticals
- 5.1.2 Scientific Research and Experiment
- 5.2 Global Aprotinin Market Size by Application
- 5.2.1 Global Aprotinin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Aprotinin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Aprotinin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Aprotinin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Aprotinin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Aprotinin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Aprotinin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Aprotinin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sigma-Aldrich
- 6.1.1 Sigma-Aldrich Company Information
- 6.1.2 Sigma-Aldrich Business Overview
- 6.1.3 Sigma-Aldrich Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sigma-Aldrich Aprotinin Product Portfolio
- 6.1.5 Sigma-Aldrich Recent Developments
- 6.2 BeiJing Geyuantianrun Bio-tech
- 6.2.1 BeiJing Geyuantianrun Bio-tech Company Information
- 6.2.2 BeiJing Geyuantianrun Bio-tech Business Overview
- 6.2.3 BeiJing Geyuantianrun Bio-tech Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BeiJing Geyuantianrun Bio-tech Aprotinin Product Portfolio
- 6.2.5 BeiJing Geyuantianrun Bio-tech Recent Developments
- 6.3 Cayman Chemical
- 6.3.1 Cayman Chemical Company Information
- 6.3.2 Cayman Chemical Business Overview
- 6.3.3 Cayman Chemical Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cayman Chemical Aprotinin Product Portfolio
- 6.3.5 Cayman Chemical Recent Developments
- 6.4 Taj Pharmaceuticals Limited
- 6.4.1 Taj Pharmaceuticals Limited Company Information
- 6.4.2 Taj Pharmaceuticals Limited Business Overview
- 6.4.3 Taj Pharmaceuticals Limited Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Taj Pharmaceuticals Limited Aprotinin Product Portfolio
- 6.4.5 Taj Pharmaceuticals Limited Recent Developments
- 6.5 Guangdong Techpool Bio-pharma
- 6.5.1 Guangdong Techpool Bio-pharma Company Information
- 6.5.2 Guangdong Techpool Bio-pharma Business Overview
- 6.5.3 Guangdong Techpool Bio-pharma Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Guangdong Techpool Bio-pharma Aprotinin Product Portfolio
- 6.5.5 Guangdong Techpool Bio-pharma Recent Developments
- 6.6 Dadeli
- 6.6.1 Dadeli Company Information
- 6.6.2 Dadeli Business Overview
- 6.6.3 Dadeli Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Dadeli Aprotinin Product Portfolio
- 6.6.5 Dadeli Recent Developments
- 6.7 A.S.Joshi&Company
- 6.7.1 A.S.Joshi&Company Company Information
- 6.7.2 A.S.Joshi&Company Business Overview
- 6.7.3 A.S.Joshi&Company Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 A.S.Joshi&Company Aprotinin Product Portfolio
- 6.7.5 A.S.Joshi&Company Recent Developments
- 6.8 Enzymeking Biotechnology
- 6.8.1 Enzymeking Biotechnology Company Information
- 6.8.2 Enzymeking Biotechnology Business Overview
- 6.8.3 Enzymeking Biotechnology Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Enzymeking Biotechnology Aprotinin Product Portfolio
- 6.8.5 Enzymeking Biotechnology Recent Developments
- 6.9 AdooQ BioScience
- 6.9.1 AdooQ BioScience Company Information
- 6.9.2 AdooQ BioScience Business Overview
- 6.9.3 AdooQ BioScience Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AdooQ BioScience Aprotinin Product Portfolio
- 6.9.5 AdooQ BioScience Recent Developments
- 6.10 ProSpec
- 6.10.1 ProSpec Company Information
- 6.10.2 ProSpec Business Overview
- 6.10.3 ProSpec Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 ProSpec Aprotinin Product Portfolio
- 6.10.5 ProSpec Recent Developments
- 6.11 Yaxin Biotechnology
- 6.11.1 Yaxin Biotechnology Company Information
- 6.11.2 Yaxin Biotechnology Business Overview
- 6.11.3 Yaxin Biotechnology Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Yaxin Biotechnology Aprotinin Product Portfolio
- 6.11.5 Yaxin Biotechnology Recent Developments
- 6.12 AMRESCO
- 6.12.1 AMRESCO Company Information
- 6.12.2 AMRESCO Business Overview
- 6.12.3 AMRESCO Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 AMRESCO Aprotinin Product Portfolio
- 6.12.5 AMRESCO Recent Developments
- 6.13 PanReac AppliChem
- 6.13.1 PanReac AppliChem Company Information
- 6.13.2 PanReac AppliChem Business Overview
- 6.13.3 PanReac AppliChem Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 PanReac AppliChem Aprotinin Product Portfolio
- 6.13.5 PanReac AppliChem Recent Developments
- 6.14 Runhao
- 6.14.1 Runhao Company Information
- 6.14.2 Runhao Business Overview
- 6.14.3 Runhao Aprotinin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Runhao Aprotinin Product Portfolio
- 6.14.5 Runhao Recent Developments
7 North America by Country
- 7.1 North America Aprotinin Sales by Country
- 7.1.1 North America Aprotinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Aprotinin Sales by Country (2021-2026)
- 7.1.3 North America Aprotinin Sales Forecast by Country (2027-2032)
- 7.2 North America Aprotinin Market Size by Country
- 7.2.1 North America Aprotinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Aprotinin Market Size by Country (2021-2026)
- 7.2.3 North America Aprotinin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Aprotinin Sales by Country
- 8.1.1 Europe Aprotinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Aprotinin Sales by Country (2021-2026)
- 8.1.3 Europe Aprotinin Sales Forecast by Country (2027-2032)
- 8.2 Europe Aprotinin Market Size by Country
- 8.2.1 Europe Aprotinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Aprotinin Market Size by Country (2021-2026)
- 8.2.3 Europe Aprotinin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Aprotinin Sales by Country
- 9.1.1 Asia-Pacific Aprotinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Aprotinin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Aprotinin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Aprotinin Market Size by Country
- 9.2.1 Asia-Pacific Aprotinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Aprotinin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Aprotinin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Aprotinin Sales by Country
- 10.1.1 South America Aprotinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Aprotinin Sales by Country (2021-2026)
- 10.1.3 South America Aprotinin Sales Forecast by Country (2027-2032)
- 10.2 South America Aprotinin Market Size by Country
- 10.2.1 South America Aprotinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Aprotinin Market Size by Country (2021-2026)
- 10.2.3 South America Aprotinin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Aprotinin Sales by Country
- 11.1.1 Middle East and Africa Aprotinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Aprotinin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Aprotinin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Aprotinin Market Size by Country
- 11.2.1 Middle East and Africa Aprotinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Aprotinin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Aprotinin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Aprotinin Value Chain Analysis
- 12.1.1 Aprotinin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Aprotinin Production Mode & Process
- 12.2 Aprotinin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Aprotinin Distributors
- 12.2.3 Aprotinin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst